Skip to main content

Merdad Parsey, M.D., Ph.D

Equibles does not estimate personal net worth.

Get an email with a short summary when Ardelyx, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARDX alerts

About Merdad Parsey, M.D., Ph.D

Merdad Parsey, M.D., Ph.D is recorded as Board Member at Ardelyx, Inc. (ARDX) since April 28, 2025. Ardelyx, Inc. reported in an 8-K filed April 29, 2025 that Merdad Parsey, M.D., Ph.D was appointed member of the Nominating and Corporate Governance Committee of the Board, effective June 18, 2025. Ardelyx, Inc. reported in an 8-K filed April 29, 2025 that Merdad Parsey, M.D., Ph.D was appointed member of the Board of Directors, effective April 28, 2025. Ardelyx, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ardelyx, Inc. includes Michael Raab (CEO and Board Member), Keith Santorelli (CFO), Susan Hohenleitner (CFO) and 7 others.

“Dr. Parsey was also appointed to serve as a member of the Nominating and Corporate Governance Committee of the Board effective June 18, 2025.”
Ardelyx, Inc. Form 8-K, filed April 29, 2025 · Read the filing
“On April 28, 2025, the Company appointed Merdad Parsey, M.D., Ph.D, as a member of the Board of Directors (the "Board") of Ardelyx, Inc., a Delaware corporation (the "Company"), effective immediately, to serve as a Class I director until the Company's 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.”
Ardelyx, Inc. Form 8-K, filed April 29, 2025 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2025-04-28–present

Leadership on record at Ardelyx, Inc.

Recent activity